Transmedics Group, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
TransMedics Group, Inc. announces its 2026 Annual Meeting of Shareholders, detailing director elections, executive compensation, stock incentive plan amendments, and auditor ratification.
NASDAQ
TransMedics Group, Inc. will hold its annual shareholder meeting on May 22, 2025, to vote on director elections, executive compensation, and auditor ratification.
NASDAQ
TransMedics Group announces its 2025 Annual Meeting of Shareholders and highlights a successful 2024 marked by significant revenue growth and profitability.
NASDAQ
TransMedics Group, Inc. announces its 2024 Annual Meeting of Shareholders to be held on May 23, 2024, outlining key proposals for voting.
NASDAQ
TransMedics Group, Inc. has released its proxy statement detailing the agenda for its upcoming annual meeting, including the election of directors, an advisory vote on executive compensation, and ratification of the company's independent auditor.